Lifeway Foods (LWAY) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 May, 2026Executive summary
Achieved record net sales of $63.0 million for Q1 2026, a 36.7% year-over-year increase, marking 26 consecutive quarters of growth.
Net income rose 32% year-over-year to $4.7 million, with EPS of $0.31 basic and $0.30 diluted.
Growth driven by flagship kefir and Farmer Cheese products, supported by consumer trends toward protein-rich, probiotic foods and successful marketing initiatives.
Expanded brand visibility through strategic partnerships, experiential marketing, and new product launches.
Remains the largest U.S. producer of kefir, focusing on health and wellness trends.
Financial highlights
Net sales reached $63.0 million, up from $46.1 million year-over-year.
Gross profit margin expanded by 360 basis points to 27.5% year-over-year.
Net income was $4.7 million, up from $3.5 million last year.
Operating income reached $6.3 million, up from $1.6 million in Q1 2025.
SG&A expenses rose 16.8% to $10.9 million, but improved as a percentage of revenue by 300 basis points.
Outlook and guidance
Waukesha facility expansion on track, expected to double capacity by Q4 2026 and boost efficiency in Q1 2027.
Expects FY 2026 to deliver the strongest annual sales in company history.
Reiterated long-term target of $45–$50 million in Adjusted EBITDA for FY 2027.
Management expects continued strong liquidity from operations, credit facility, and cash reserves.
Anticipates continued growth fueled by health-conscious consumer trends and increased demand for probiotic foods.
Latest events from Lifeway Foods
- Proxy covers director elections, auditor ratification, and executive pay, highlighting governance and ESG.LWAY
Proxy filing1 May 2026 - Votes will be cast on board elections, auditor ratification, and executive pay at the 2026 meeting.LWAY
Proxy filing30 Apr 2026 - Record sales and profit growth, margin expansion, and innovation drive strong 2026 outlook.LWAY
Q4 202517 Mar 2026 - Q2 net sales rose 25.3% to $49.2M, net income hit $3.8M, and all debt was repaid.LWAY
Q2 20241 Feb 2026 - Q3 2024 sales up 12.7%, net income $3M, global expansion, and Danone bid rejected.LWAY
Q3 202414 Jan 2026 - ISS backs the full board slate for the 2025 meeting, urging shareholders to vote accordingly.LWAY
Proxy Filing19 Dec 2025 - Up to 3.45 million shares are being resold by a major shareholder as part of a governance agreement.LWAY
Registration Filing16 Dec 2025 - Board refreshes with independent directors, urges rejection of dissident nominees amid strong results.LWAY
Proxy Filing11 Dec 2025 - Proxy contest targets board overhaul, new oversight committee, and governance reforms.LWAY
Proxy Filing5 Dec 2025